Osaic Holdings’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.99M | Buy |
48,479
+4,816
| +11% | +$198K | ﹤0.01% | 1667 |
|
|
2025
Q1 | $1.49M | Sell |
43,663
-6,253
| -13% | -$213K | ﹤0.01% | 1901 |
|
|
2024
Q4 | $1.94M | Sell |
49,916
-34,888
| -41% | -$1.36M | ﹤0.01% | 1691 |
|
|
2024
Q3 | $3.98M | Sell |
84,804
-3,597
| -4% | -$169K | 0.01% | 1191 |
|
|
2024
Q2 | $4.77M | Sell |
88,401
-2,650
| -3% | -$143K | 0.01% | 1026 |
|
|
2024
Q1 | $6.2M | Buy |
91,051
+582
| +0.6% | +$39.7K | 0.01% | 912 |
|
|
2023
Q4 | $5.66M | Sell |
90,469
-13,052
| -13% | -$817K | 0.01% | 1102 |
|
|
2023
Q3 | $4.7M | Buy |
103,521
+18,300
| +21% | +$831K | 0.01% | 1344 |
|
|
2023
Q2 | $4.79M | Buy |
85,221
+191
| +0.2% | +$10.7K | 0.01% | 1212 |
|
|
2023
Q1 | $3.84M | Buy |
85,030
+16,115
| +23% | +$729K | 0.01% | 1341 |
|
|
2022
Q4 | $2.8M | Buy |
68,915
+17,866
| +35% | +$726K | 0.01% | 1501 |
|
|
2022
Q3 | $3.34M | Buy |
51,049
+119
| +0.2% | +$7.77K | 0.01% | 1271 |
|
|
2022
Q2 | $3.12M | Sell |
50,930
-630
| -1% | -$38.6K | 0.01% | 1343 |
|
|
2022
Q1 | $3.07M | Buy |
51,560
+3,461
| +7% | +$206K | 0.01% | 1573 |
|
|
2021
Q4 | $3.66M | Buy |
48,099
+6,116
| +15% | +$466K | 0.01% | 1313 |
|
|
2021
Q3 | $4.7M | Buy |
41,983
+7,020
| +20% | +$785K | 0.01% | 1097 |
|
|
2021
Q2 | $5.65M | Buy |
34,963
+4,920
| +16% | +$794K | 0.01% | 977 |
|
|
2021
Q1 | $3.65M | Buy |
30,043
+12,476
| +71% | +$1.52M | 0.01% | 1143 |
|
|
2020
Q4 | $2.69M | Sell |
17,567
-4,103
| -19% | -$629K | 0.01% | 1226 |
|
|
2020
Q3 | $1.81M | Buy |
21,670
+2,271
| +12% | +$190K | 0.01% | 1369 |
|
|
2020
Q2 | $1.43M | Buy |
19,399
+222
| +1% | +$16.3K | ﹤0.01% | 1480 |
|
|
2020
Q1 | $821K | Buy |
+19,177
| New | +$821K | ﹤0.01% | 1681 |
|